BODIPY™ FL Sulfonated Succinimidyl Ester
BODIPY™ FL Sulfonated Succinimidyl Ester
Invitrogen™

BODIPY™ FL Sulfonated Succinimidyl Ester

L’ester sulfosuccinimidylique réactif aux amines BODIPY® FL peut être utilisé pour créer des bioconjugués fluorescents verts. Cette fraction réactive estAfficher plus
Have Questions?
RéférenceQuantité
D61405 mg
Référence D6140
Prix (EUR)
547,65
Online Exclusive
730,00
Économisez 182,35 (25%)
Each
Ajouter au panier
Quantité:
5 mg
Prix (EUR)
547,65
Online Exclusive
730,00
Économisez 182,35 (25%)
Each
Ajouter au panier
L’ester sulfosuccinimidylique réactif aux amines BODIPY® FL peut être utilisé pour créer des bioconjugués fluorescents verts. Cette fraction réactive est sulfonée pour augmenter la solubilité dans l’eau. Le colorant BODIPY® FL électroniquement neutre présente les spectres les plus proches de la fluorescéine des colorants BODIPY® fluorescents verts.
Usage exclusivement réservé à la recherche. Ne pas utiliser pour des procédures de diagnostic.
Spécifications
Réactivité chimiqueAmine
Marqueur ou colorantBODIPY™ FL
Type de produitEster succinimidyle sulfoné FL
Quantité5 mg
Groupement de réactifsEster actif, ester de succinimidyle
Conditions d’expéditionTempérature ambiante
Type d’étiquetteColorants BODIPY
Gamme de produitsBODIPY
Unit SizeEach
Contenu et stockage
Conserver au congélateur (-5 à -30°C) à l’abri de la lumière.

Citations et références (5)

Citations et références
Abstract
Fluorescent quenching-based quantitative detection of specific DNA/RNA using a BODIPY((R)) FL-labeled probe or primer.
Authors:Kurata S, Kanagawa T, Yamada K, Torimura M, Yokomaku T, Kamagata Y, Kurane R
Journal:Nucleic Acids Res
PubMed ID:11239011
We have developed a simple method for the quantitative detection of specific DNA or RNA molecules based on the finding that BODIPY((R)) FL fluorescence was quenched by its interaction with a uniquely positioned guanine. This approach makes use of an oligonucleotide probe or primer containing a BODIPY((R)) FL-modified cytosine at ... More
Ultrasensitive fluorescence-based detection of nascent proteins in gels.
Authors:Gite S, Mamaev S, Olejnik J, Rothschild K
Journal:Anal Biochem
PubMed ID:10706791
The most common method of analysis of proteins synthesized in a cell-free translation system (e.g., nascent proteins) involves the use of radioactive amino acids such as [(35)S]methionine or [(14)C]leucine. We report a sensitive, nonisotopic, fluorescence-based method for the detection of nascent proteins directly in polyacrylamide gels. A fluorescent reporter group ... More
Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1.
Authors:Vishnyakova TG, Bocharov AV, Baranova IN, Chen Z, Remaley AT, Csako G, Eggerman TL, Patterson AP
Journal:J Biol Chem
PubMed ID:12651854
Scavenger receptor, class B, type I (SR-BI) mediates selective uptake of high density lipoprotein (HDL) cholesteryl ester. SR-BI recognizes HDL, low density lipoprotein (LDL), exchangeable apolipoproteins, and protein-free lipid vesicles containing negatively charged phospholipids. Lipopolysaccharides (LPS) are highly glycosylated anionic phospholipids contributing to septic shock. Despite significant structural similarities between ... More
Synthesis of fluorescent analogs of alpha-conotoxin MII.
Authors:Vishwanath VA, McIntosh JM
Journal:Bioconjug Chem
PubMed ID:17105243
Alpha-conotoxins (alpha-CTxs) are small peptides that are competitive inhibitors of nicotinic acetylcholine receptors (nAChRs) and have been used to study the kinetics of nAChRs. Alpha-CTx MII, from the venom of Conus magus, has been shown to potently block both rat alpha3beta2 and rat chimeric alpha6/alpha3beta2beta3 cloned nAChRs expressed in Xenopus ... More
A high-throughput nonisotopic protein truncation test.
Authors:Gite S, Lim M, Carlson R, Olejnik J, Zehnbauer B, Rothschild K
Journal:Nat Biotechnol
PubMed ID:12524552
Nonsense or frameshift mutations, which result in a truncated gene product, are prevalent in a variety of disease-related genes, including APC (implicated in colorectal cancer), BRCA1 and BRCA2 (breast and ovarian cancer), PKD1 (polycystic kidney disease), NF1 and NF2 (neurofibromatosis), and DMD (Duchenne muscular dystrophy). Such chain-truncating mutations can be ... More